Dr. irit milman krentsis | Stem cell transplantation | Best Researcher Award
senior research MD Anderson United States
🌟 Irit Milman Krentsis, Ph.D. is a seasoned immunologist and clinical project director based in Houston, Texas. With over 17 years of experience, she has made significant contributions to mammalian embryonic stem cell research, organ development, and transplantation immunology. Dr. Milman Krentsis is known for her expertise in clinical-grade research and her proficiency in managing complex scientific projects.
Profile
Education
🎓 Education: Dr. Milman Krentsis holds a Ph.D. in Immunology from the Weizmann Institute of Science (2012-2017). She also earned an M.Sc. in Human Genetics (2007-2009) and a B.Sc. in Chemistry and Biology (2004-2009) from the Hebrew University of Jerusalem. Her postdoctoral fellowship was completed at the Weizmann Institute of Science (2017-2018).
Experience
💼 Experience: Currently a senior research scientist at MD Anderson Cancer Center, Dr. Milman Krentsis leads projects focused on lung fibrosis. Previously, she was a computational scientist specializing in stem cell transplantation at the same institution. She has also worked as a postdoctoral fellow at the Weizmann Institute of Science and held research assistant roles at Hadassah Medical Center and Hebrew University.
Research Interest
🔬 Research Interest: Dr. Milman Krentsis’s research interests lie in immunology, stem cell transplantation, lung regeneration, and tissue engineering. She is particularly focused on developing treatments for idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD) using innovative stem cell techniques.
Awards
🏅 Awards: Dr. Milman Krentsis has received numerous accolades, including the Excellence Scholarship from the Genetic Department at Hebrew University in 2005. Her contributions have been recognized through various grants and patents in the field of lung transplantation and regenerative medicine.
Publications Top Notes
📚 Publications: Dr. Milman Krentsis has published extensively in peer-reviewed journals. Some notable publications include:
Lung Cell Transplantation for Treatment of Lung Fibrosis, Science Advances, 2024. Cited by 5 articles.
Primer on Fibroblast Growth Factor 7, Differentiation, 2024. Cited by 3 articles.
Identification of a Multipotent Lung Progenitor for Lung Regeneration, BioRxiv, 2022. Cited by 4 articles.
Lung Regeneration by Transplantation of Allogeneic Lung Progenitors, Stem Cells Translational Medicine (SCTM), 2022. Cited by 6 articles.
Multi-lineage Lung Regeneration by Stem Cell Transplantation, Cell Reports, 2020. Cited by 10 articles.